US and Indian Health Officials Renew the Indo-US Vaccine Action Program (IMAGE)

NIH/National Institute of Allergy and Infectious Diseases

US and Indian Health Officials Renew the Indo-US Vaccine Action Program

Caption

On May 3, NIH and Indian officials signed a Joint Statement to renew the successful 20-year-old Indo-US Vaccine Action program for another five years. (Standing from left) Dr. S. Natesh, adviser scientist, Indian Department of Biotechnology; National Institutes of Health Director Dr. Elias A. Zerhouni; National Institute of Allergy and Infectious Diseases Director Dr. Anthony S. Fauci; Fogarty International Center Director Dr. Roger Glass; Secretary of the Indian Department of Biotechnology Dr. Maharaj K. Bhan; and Science and Technology Counselor from the Embassy of India, Dr. Kamal Kant Dwivedi.

Credit

National Institute of Allergy and Infectious Diseases

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.